nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Clinical management of HIV-1 resistance
|
Paredes, Roger |
|
2010 |
85 |
1 |
p. 245-265 21 p. |
artikel |
2 |
Current status and challenges of antiretroviral research and therapy
|
Esté, José A. |
|
2010 |
85 |
1 |
p. 25-33 9 p. |
artikel |
3 |
Development of topical microbicides to prevent the sexual transmission of HIV
|
Buckheit Jr., Robert W. |
|
2010 |
85 |
1 |
p. 142-158 17 p. |
artikel |
4 |
Early nucleoside reverse transcriptase inhibitors for the treatment of HIV: A brief history of stavudine (D4T) and its comparison with other dideoxynucleosides
|
Martin, John C. |
|
2010 |
85 |
1 |
p. 34-38 5 p. |
artikel |
5 |
Editorial Board
|
|
|
2010 |
85 |
1 |
p. ii- 1 p. |
artikel |
6 |
Effector mechanisms in HIV-1 infected elite controllers: Highly active immune responses?
|
Blankson, Joel N. |
|
2010 |
85 |
1 |
p. 295-302 8 p. |
artikel |
7 |
Entry inhibitors in the treatment of HIV-1 infection
|
Tilton, John C. |
|
2010 |
85 |
1 |
p. 91-100 10 p. |
artikel |
8 |
Evaluation of antiretrovirals in animal models of HIV infection
|
Van Rompay, Koen K.A. |
|
2010 |
85 |
1 |
p. 159-175 17 p. |
artikel |
9 |
Fifteen years of HIV Protease Inhibitors: raising the barrier to resistance
|
Wensing, Annemarie M.J. |
|
2010 |
85 |
1 |
p. 59-74 16 p. |
artikel |
10 |
HIV reservoirs, latency, and reactivation: Prospects for eradication
|
Dahl, Viktor |
|
2010 |
85 |
1 |
p. 286-294 9 p. |
artikel |
11 |
In search of a selective therapy of viral infections
|
De Clercq, Erik |
|
2010 |
85 |
1 |
p. 19-24 6 p. |
artikel |
12 |
Molecular basis of human immunodeficiency virus drug resistance: An update
|
Menéndez-Arias, Luis |
|
2010 |
85 |
1 |
p. 210-231 22 p. |
artikel |
13 |
Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: A review of the last 20 years (1989–2009)
|
de Béthune, Marie-Pierre |
|
2010 |
85 |
1 |
p. 75-90 16 p. |
artikel |
14 |
Notes to Authors
|
|
|
2010 |
85 |
1 |
p. CO3- 1 p. |
artikel |
15 |
Novel approaches to inhibiting HIV-1 replication
|
Adamson, Catherine S. |
|
2010 |
85 |
1 |
p. 119-141 23 p. |
artikel |
16 |
Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine
|
Cihlar, Tomas |
|
2010 |
85 |
1 |
p. 39-58 20 p. |
artikel |
17 |
Pharmacogenetics of antiretrovirals
|
Tozzi, Valerio |
|
2010 |
85 |
1 |
p. 190-200 11 p. |
artikel |
18 |
Pharmacokinetics and drug–drug interactions of antiretrovirals: An update
|
Dickinson, Laura |
|
2010 |
85 |
1 |
p. 176-189 14 p. |
artikel |
19 |
Running a tightrope: Regulatory challenges in the development of antiretrovirals
|
Naeger, Lisa K. |
|
2010 |
85 |
1 |
p. 232-240 9 p. |
artikel |
20 |
Sexual transmission of HIV-1
|
Fox, Julie |
|
2010 |
85 |
1 |
p. 276-285 10 p. |
artikel |
21 |
Strand transfer inhibitors of HIV-1 integrase: Bringing IN a new era of antiretroviral therapy
|
McColl, Damian J. |
|
2010 |
85 |
1 |
p. 101-118 18 p. |
artikel |
22 |
The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic
|
Broder, Samuel |
|
2010 |
85 |
1 |
p. 1-18 18 p. |
artikel |
23 |
The evolution of HIV treatment guidelines: Current state-of-the-art of ART
|
Zolopa, Andrew R. |
|
2010 |
85 |
1 |
p. 241-244 4 p. |
artikel |
24 |
Understanding and managing the adverse effects of antiretroviral therapy
|
Hawkins, Trevor |
|
2010 |
85 |
1 |
p. 201-209 9 p. |
artikel |
25 |
Update on antiretroviral therapy in paediatrics
|
Penazzato, Martina |
|
2010 |
85 |
1 |
p. 266-275 10 p. |
artikel |
26 |
Viral hepatitis and HIV co-infection
|
Soriano, Vincent |
|
2010 |
85 |
1 |
p. 303-315 13 p. |
artikel |